BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787-794. [PMID: 18036765 DOI: 10.1016/j.ejso.2007.10.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Ganeshan D, Moron FE, Szklaruk J. Extrahepatic biliary cancer: New staging classification. World J Radiol 2012; 4(8): 345-352 [PMID: 22937214 DOI: 10.4329/wjr.v4.i8.345] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
2 Azoulay D, Pascal G, Salloum C, Adam R, Castaing D, Tranecol N. Vascular reconstruction combined with liver resection for malignant tumours. Br J Surg. 2013;100:1764-1775. [PMID: 24227362 DOI: 10.1002/bjs.9295] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
3 Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol. 2014;26:1047-1054. [PMID: 25051217 DOI: 10.1097/meg.0000000000000162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
4 Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y, Jiang C, Sun X, Xu F, Zhang Y. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer. 2012;130:2155-2163. [PMID: 21387295 DOI: 10.1002/ijc.26019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
5 Liu Y, Li G, Lu Z, Wang T, Yang Y, Wang X, Liu J. Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis. PeerJ 2021;9:e12184. [PMID: 34631316 DOI: 10.7717/peerj.12184] [Reference Citation Analysis]
6 Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg 2014;399:707-16. [DOI: 10.1007/s00423-014-1216-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
7 Higuchi R, Yazawa T, Uemura S, Izumo W, Ota T, Kiyohara K, Furukawa T, Egawa H, Yamamoto M. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion. J Gastrointest Surg 2019;23:1443-53. [PMID: 30203230 DOI: 10.1007/s11605-018-3948-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2013;15:492-503. [PMID: 23750491 DOI: 10.1111/j.1477-2574.2012.00616.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
9 Saito H, Noji T, Okamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery 2016;159:842-51. [DOI: 10.1016/j.surg.2015.10.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
10 Skipworth JR, Keane MG, Pereira SP. Update on the management of cholangiocarcinoma. Dig Dis 2014;32:570-8. [PMID: 25034290 DOI: 10.1159/000360507] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
11 Robles R, Parrilla P, Ramírez P, Sánchez-Bueno F, Marín C, Pastor P, Pons JA, Acosta F, Pérez-Flores D, De La Peña Morales J. [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour]. Cir Esp 2010;87:82-8. [PMID: 20074713 DOI: 10.1016/j.ciresp.2009.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Berumen J, Hemming A. Vascular Reconstruction in Hepatic Malignancy. Surg Clin North Am 2016;96:283-98. [PMID: 27017865 DOI: 10.1016/j.suc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
13 Ohtsubo I, Ajiki T, Hori Y, Murakami S, Shimizu K, Itoh T, Shimizu M, Fukumoto T, Ku Y. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas: CD133 expression in IPNB. Hepatology Research 2012;42:574-82. [DOI: 10.1111/j.1872-034x.2011.00954.x] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hu HJ, Zhou RX, Shrestha A, Tan YQ, Ma WJ, Yang Q, Lu J, Wang JK, Zhou Y, Li FY. Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma. Oncotarget 2017;8:105011-9. [PMID: 29285229 DOI: 10.18632/oncotarget.22054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
16 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
17 Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot FR, Regimbeau J. Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. Journal of Hepatology 2012;56:1121-8. [DOI: 10.1016/j.jhep.2011.12.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
18 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
19 Kostalas M, Frampton AE, Low N, Lahiri R, Ban EJ, Kumar R, Riga AT, Worthington TR, Karanjia ND. Left hepatic trisectionectomy for hepatobiliary malignancies: Its' role and outcomes. A retrospective cohort study. Ann Med Surg (Lond) 2020;51:11-6. [PMID: 31993198 DOI: 10.1016/j.amsu.2019.11.016] [Reference Citation Analysis]
20 Carroll JE Jr, Hurwitz ZM, Simons JP, McPhee JT, Ng SC, Shah SA, Al-Refaie WB, Tseng JF. In-hospital mortality after resection of biliary tract cancer in the United States. HPB (Oxford) 2010;12:62-7. [PMID: 20495647 DOI: 10.1111/j.1477-2574.2009.00129.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
22 Boutros C, Somasundar P, Espat NJ. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009;18:269-88. [DOI: 10.1016/j.soc.2008.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Wang H, Wang H, Chen T, Liang X, Song Y, Wang J. Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma. World J Surg Oncol 2014;12:191. [PMID: 24961847 DOI: 10.1186/1477-7819-12-191] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Molnár FT, Horváth OP, Farkas L, Gerlinger I, Pajor L, Kelemen D, Kalmár Nagy K, Tizedes G, Pavlovics G, Bódis J, Gocze P, Szekeres G. [From the surgical field to the microscope. A new tool to identify the lymph node specimens in oncologic surgery]. Magy Seb 2011;64:6-11. [PMID: 21330257 DOI: 10.1556/MaSeb.64.2011.1.2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Schaefer B, Zoller H, Schneeberger S. Con: Liver transplantation for expanded criteria malignant diseases. Liver Transpl. 2018;24:104-111. [PMID: 29125687 DOI: 10.1002/lt.24975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Acher AW, Weber SM, Pawlik TM. Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes. Expert Rev Gastroenterol Hepatol 2021;15:555-66. [PMID: 33577361 DOI: 10.1080/17474124.2021.1890584] [Reference Citation Analysis]
27 Chen P, Li B, Zhu Y, Chen W, Liu X, Li M, Duan X, Yi B, Wang J, Liu C, Luo X, Li X, Li J, Liang L, Yin X, Wang H, Jiang X. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma. Oncotarget 2016;7:37319-30. [PMID: 27144432 DOI: 10.18632/oncotarget.9104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
28 Noji T, Tsuchikawa T, Okamura K, Nakamura T, Tamoto E, Shichinohe T, Hirano S. Resection and reconstruction of the hepatic artery for advanced perihilar cholangiocarcinoma: result of arterioportal shunting. J Gastrointest Surg. 2015;19:675-681. [PMID: 25650165 DOI: 10.1007/s11605-015-2754-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol 2013; 19(48): 9209-9215 [PMID: 24409049 DOI: 10.3748/wjg.v19.i48.9209] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
30 Liu W, Tian F, Jiang P, Zhao X, Guo F, Li X, Wang S. Aberrant expression of laminin γ2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma. J Surg Res. 2014;186:150-156. [PMID: 24124977 DOI: 10.1016/j.jss.2013.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
31 Radulova-Mauersberger O, Weitz J, Riediger C. Vascular surgery in liver resection. Langenbecks Arch Surg 2021;406:2217-48. [PMID: 34519878 DOI: 10.1007/s00423-021-02310-w] [Reference Citation Analysis]
32 Mekeel KL, Hemming AW. Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy. Hepat Oncol 2014;1:53-65. [PMID: 30190941 DOI: 10.2217/hep.13.5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
33 Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, Chung JB, Kim KS. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg 2012;16:1672-9. [PMID: 22798185 DOI: 10.1007/s11605-012-1960-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
34 De Lu C, Huang J, Wu SD, Hua YF, Javed AA, Fang JZ, Wang CN, Ye S. Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video). J Gastrointest Surg 2017;21:1906-14. [PMID: 28875398 DOI: 10.1007/s11605-017-3561-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Peng C, Li C, Wen T, Yan L, Li B. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study. Int J Surg 2016;32:167-73. [PMID: 27344254 DOI: 10.1016/j.ijsu.2016.06.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
36 Kawamura T, Noji T, Okamura K, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, Kurashima Y, Nakamura T, Murakami S, Tsuchikawa T, Shichinohe T, Hirano S. Postoperative Liver Failure Criteria for Predicting Mortality after Major Hepatectomy with Extrahepatic Bile Duct Resection. Dig Surg 2019;36:158-65. [DOI: 10.1159/000486906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
37 Lin Q, Lin ZH, Chen J, Lin JX, Li X, Jiang JR, Ma XK, Wu DH, Chen ZH, Dong M, Wei L, Wang TT, Ruan DY, Lin ZX, Wen JY, Wu XY, Huang MS. Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma. Curr Res Transl Med. 2017;65:83-87. [PMID: 28684265 DOI: 10.1016/j.retram.2017.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Machairas N, Kostakis ID, Tsilimigras DI, Prodromidou A, Moris D. Liver transplantation for hilar cholangiocarcinoma: A systematic review. Transplant Rev (Orlando). 2020;34:100516. [PMID: 31711828 DOI: 10.1016/j.trre.2019.100516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases. J Hepatobiliary Pancreat Sci 2019;26:490-502. [PMID: 31520452 DOI: 10.1002/jhbp.668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
40 Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C, Ran RZ, Yan PN, Zhang BH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012;38:1197-1203. [PMID: 22992326 DOI: 10.1016/j.ejso.2012.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
41 Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, Hayashi H, Motoi F, Egawa S. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469. [PMID: 19941010 DOI: 10.1007/s00534-009-0206-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
42 Zheng-rong L, Hai-bo Y, Xin C, Chuan-xin W, Zuo-jin L, Bing T, Jian-ping G, Sheng-wei L. Resection and Drainage of Hilar Cholangiocarcinoma: An 11-Year Experience of a Single Center in Mainland China. The American Surgeon 2011;77:627-33. [DOI: 10.1177/000313481107700525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Zou Z, Zheng B, Li J, Lv X, Zhang H, Yu F, Kong L, Li Y, Yu M, Fang L, Liang B. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT. Biomedicine & Pharmacotherapy 2018;107:1286-93. [DOI: 10.1016/j.biopha.2018.08.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
44 Ni Q, Wang H, Zhang Y, Qian L, Chi J, Liang X, Chen T, Wang J. MDCT assessment of resectability in hilar cholangiocarcinoma. Abdom Radiol (NY). 2017;42:851-860. [PMID: 27770159 DOI: 10.1007/s00261-016-0943-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
45 Donati M, Stang A, Stavrou GA, Basile F, Oldhafer KJ. Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved? Future Oncol 2019;15:193-205. [PMID: 30378439 DOI: 10.2217/fon-2018-0413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
47 Chauhan A, House MG, Pitt HA, Nakeeb A, Howard TJ, Zyromski NJ, Schmidt CM, Ball CG, Lillemoe KD. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139-147. [PMID: 21241432 DOI: 10.1111/j.1477-2574.2010.00262.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
48 Chua D, Low A, Koh Y, Goh B, Cheow PC, Kam JH, Teo JY, Tan EK, Chung A, Ooi LL, Chan CY, Lee SY. A retrospective review of correlative radiological assessment and surgical exploration for hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:216-22. [PMID: 30215043 DOI: 10.14701/ahbps.2018.22.3.216] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Moris D, Kostakis ID, Machairas N, Prodromidou A, Tsilimigras DI, Ravindra KV, Sudan DL, Knechtle SJ, Barbas AS. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. PLoS One. 2019;14:e0220527. [PMID: 31365594 DOI: 10.1371/journal.pone.0220527] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
50 Young AL, Prasad KR, Adair R, Abu Hilal M, Guthrie JA, Lodge JP. Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. J Am Coll Surg 2008;207:e1-6. [PMID: 18954768 DOI: 10.1016/j.jamcollsurg.2008.07.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
51 Qiu J, Wu H, Prasoon P, Zeng Y. Portal vein arterialization in hilar cholangiocarcinoma: one case report and literature review. Eur J Gastroenterol Hepatol 2012;24:229-32. [PMID: 22186189 DOI: 10.1097/MEG.0b013e32834f8d02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
52 Mehrabi A, Khajeh E, Ghamarnejad O, Nikdad M, Chang D, Büchler MW, Hoffmann K. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. European Journal of Radiology 2020;125:108897. [DOI: 10.1016/j.ejrad.2020.108897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Hu HJ, Jin YW, Zhou RX, Shrestha A, Ma WJ, Yang Q, Wang JK, Liu F, Cheng NS, Li FY. Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required? J Gastrointest Surg. 2018;22:1204-1212. [PMID: 29512002 DOI: 10.1007/s11605-018-3711-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. British Journal of Surgery 2010;97:1363-8. [DOI: 10.1002/bjs.7122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
55 Wyatt JI. Cholangiocarcinoma – new concepts and classifications. Diagnostic Histopathology 2011;17:539-47. [DOI: 10.1016/j.mpdhp.2011.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
56 Rebelo A, Ukkat J, Klose J, Ronellenfitsch U, Kleeff J. Surgery With Arterial Resection for Hilar Cholangiocarcinoma: Protocol for a Systematic Review and Meta-analysis. JMIR Res Protoc 2021;10:e31212. [PMID: 34609321 DOI: 10.2196/31212] [Reference Citation Analysis]
57 Hu HJ, Mao H, Tan YQ, Shrestha A, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma. Springerplus. 2016;5:551. [PMID: 27190750 DOI: 10.1186/s40064-016-2181-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
58 Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl. 2009;15:1499-1507. [PMID: 19877250 DOI: 10.1002/lt.21887] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
59 Young AL, Prasad KR, Toogood GJ, Lodge JP. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci. 2010;17:497-504. [PMID: 19859651 DOI: 10.1007/s00534-009-0203-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
60 Young AL, Igami T, Senda Y, Adair R, Farid S, Toogood GJ, Prasad KR, Lodge JP. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford). 2011;13:483-493. [PMID: 21689232 DOI: 10.1111/j.1477-2574.2011.00328.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
61 Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, Nishikimi N, Kamei Y. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115-123. [PMID: 20531001 DOI: 10.1097/sla.0b013e3181e463a7] [Cited by in Crossref: 201] [Cited by in F6Publishing: 70] [Article Influence: 18.3] [Reference Citation Analysis]
62 Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
63 de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg. 2011;146:697-703. [PMID: 21690446 DOI: 10.1001/archsurg.2011.122] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
64 Farid SG, Craven RA, Peng J, Bonney GK, Perkins DN, Selby PJ, Rajendra Prasad K, Banks RE. Shotgun proteomics of human bile in hilar cholangiocarcinoma. Proteomics. 2011;11:2134-2138. [PMID: 21500345 DOI: 10.1002/pmic.201000653] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
65 Cannon RM, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford). 2012;14:142-149. [PMID: 22221577 DOI: 10.1111/j.1477-2574.2011.00419.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
66 Cambridge WA, Fairfield C, Powell JJ, Harrison EM, Søreide K, Wigmore SJ, Guest RV. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma.Ann Surg. 2021;273:240-250. [PMID: 32097164 DOI: 10.1097/SLA.0000000000003801] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 16.0] [Reference Citation Analysis]
67 Tian F, Li D, Chen J, Liu W, Cai L, Li J, Jiang P, Liu Z, Zhao X, Guo F, Li X, Wang S. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Eur J Cancer 2013;49:1771-80. [PMID: 23313142 DOI: 10.1016/j.ejca.2012.12.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
68 Li J, Zhao L, Zhang J, Li Z, Li A, Wei Y, Xu J. Application of the laparoscopic technique in perihilar cholangiocarcinoma surgery. Int J Surg 2017;44:104-9. [PMID: 28629770 DOI: 10.1016/j.ijsu.2017.06.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
69 Ma D, Wang W, Wang J, Zhang T, Jiang Z, Du G, Yang J, Zhang X, Qin G, Jin B. Laparoscopic versus open surgery for hilar cholangiocarcinoma: a retrospective cohort study on short-term and long-term outcomes. Surg Endosc 2021. [PMID: 34398281 DOI: 10.1007/s00464-021-08686-6] [Reference Citation Analysis]
70 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 139-146 [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
71 Chen KJ, Yang FC, Qin YS, Jin J, Zheng SS. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2018;17:155-162. [PMID: 29636302 DOI: 10.1016/j.hbpd.2018.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
72 Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Tanaka E, Hirano S. Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy. J Gastrointest Surg 2014;18:1131-7. [DOI: 10.1007/s11605-014-2490-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Lamarca A, Edeline J, McNamara MG, Hubner RA, Nagino M, Bridgewater J, Primrose J, Valle JW. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev. 2020;84:101936. [PMID: 31986437 DOI: 10.1016/j.ctrv.2019.101936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
74 Pan H, Liang Z, Yin TS, Xie Y, Li DW. Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice. Med Oncol 2014;31:853. [PMID: 24464214 DOI: 10.1007/s12032-014-0853-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
75 She WH, Cheung TT, Ma KW, Tsang SHY, Dai WC, Chan ACY, Lo CM. Vascular resection and reconstruction in hilar cholangiocarcinoma. ANZ J Surg 2020;90:1653-9. [PMID: 32458528 DOI: 10.1111/ans.15969] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329-337. [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
77 Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023-4035. [PMID: 20005336 DOI: 10.1016/j.transproceed.2009.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
78 Feng F, Wu X, Shi X, Gao Q, Wu Y, Yu Y, Cheng Q, Li B, Yi B, Liu C, Hao Q, Zhang L, Gao C, Jiang X. Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. Int J Clin Oncol 2021;26:717-27. [PMID: 33387086 DOI: 10.1007/s10147-020-01846-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]